Covid-19: Serum Institute’s Adar Poonawalla appeals to govt to reduce time gap for booster dose to six months

Covid-19: Serum Institute’s Adar Poonawalla appeals to govt to reduce time gap for booster dose to six months

Vaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to six months from nine months at present to safeguard people against emerging COVID variants, according to its CEO Adar Poonawalla. Recalling that they could not meet the commitment of exporting vaccines in … Read more

Bharat Biotech seeks nod for phase-3 trials of intranasal COVID-19 vaccine as booster dose

Bharat Biotech

An intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to prevent transmission. Bharat Biotech has sought the Drug Controller General of India’s approval to conduct phase-3 trials of its COVID-19 intranasal vaccine (BBV154) to use as booster dose, sources said on Monday. “The application … Read more